// App-Quantinova.ai

SP0200 : APOER2 AS A MEDIATOR OF THE ANTIPHOSPHOLIPID SYNDROME

Researchers

Presenter

  • C. Mineo

Principal Investigators

  • N/A

Medical Centers

  • UT Southwestern Medical Center, Dallas, Texas, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Antiphospholipid syndrome

  • Vasodilation dysfunction

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • Nitric oxide

  • Defensin Beta 1

  • Endothelial cell nitric oxide synthase

  • Immunoglobulin G

Drug/Treatment

  • Nitric oxide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved